RxDoctor Payments Data

Mari Bridges, MD

Family Medicine · Barnwell, SCNPI 1740543164

Payments from drug & device makers

$1,780in general payments, 2019–2025

Across 96 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$446
  • Lilly USA, LLC$234
  • Boehringer Ingelheim$213
  • Pfizer$150
  • Novo Nordisk$137
  • Takeda Pharmaceuticals U.S.A., Inc.$88
  • plus $512 from 14 others

What the payments were for

  • Food & beverage$1,780100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,780 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$3,678
Medicare patients
119
Services billed
304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin100$112,918
OzempicSemaglutide92$92,649
JanuviaSitagliptin Phosphate47$72,722
TrulicityDulaglutide72$70,606
MounjaroTirzepatide59$66,387
FarxigaDapagliflozin Propanediol51$60,566
EliquisApixaban31$44,803
ZenpepLipase/Protease/Amylase12$37,119
VraylarCariprazine Hcl18$27,561
TradjentaLinagliptin17$26,765
EntrestoSacubitril/Valsartan30$21,588
RybelsusSemaglutide14$21,289
GlyxambiEmpagliflozin/Linagliptin18$20,859
LinzessLinaclotide21$15,849
JanumetSitagliptin Phos/Metformin Hcl23$15,655

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Spiriva Respimat$213$167,937149 claims
Lilly USA, LLCTrulicity, Mounjaro$234$136,993131 claims
Novo NordiskOzempic, Rybelsus$137$113,938106 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$65$77,99288 claims
PfizerEliquis$150$44,80331 claims
AbbVieVraylar, Linzess$446$43,41039 claims
GSKTrelegy Ellipta, Breo Ellipta$85$19,46427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Barnwell

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →